Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution

Panitumumab (Pmab) is generally considered to be ineffective after the failure of cetuximab (Cmab) therapy in metastatic colorectal cancer (mCRC) patients. However, a few studies have demonstrated that Pmab is an effective treatment for disease progression following Cmab-based regimens in the USA. I...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: SONODA, HIROMICHI, MEKATA, EIJI, SHIMIZU, TOMOHARU, ENDO, YOSHIHIRO, TANI, TOHRU
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2013
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628964/
https://ncbi.nlm.nih.gov/pubmed/23599789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1171
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker